Chemokines are best known as signalling molecules that attract leukocytes to sites of inflammation, but recent results show they are also important regulators of hematopoiesis during development.
Chemokines are being discovered with increasing rapidity, and the chemokine family now numbers well over 30 proteins [1] . They fall into two major subfamilies, distinguished structurally by the configuration of the two characteristic cysteine residues near the amino terminus: the ␣-chemokines, with configuration C-X-C, and the ␤-chemokines, with configuration C-C. The ␣-chemokines include interleukin-8 (IL-8), melanoma growth stimulatory activity (MGSA), neutrophil-activating peptide-2 and platelet factor 4; the ␤-chemokines include RANTES, macrophage inhibitory proteins (MIPs) 1␣ and 1␤, and monocyte chemoattractant protein-1 (MCP-1). Recently, lymphotactin, a 'chemokine' with only one aminoproximal cysteine residue has been described [2] , but the physiological role of this protein is obscure, and it remains to be seen whether it is a founding member of a third chemokine superfamily or just a molecular oddity.
Chemokines transduce their signals through cell-surface receptors of the heptahelical receptor superfamily, which couple to trimeric guanine-nucleotide-binding (G) proteins [3] . An individual receptor may bind one or more chemokines in the same subfamily [3] . Receptors that bind to selected chemokines of both C-X-C and C-C subfamilies have been described -the Duffy receptor is an example -but so far they are of undetermined function [4] . The ligand-binding repertoires of different receptors significantly overlap, as do the sets of chemokine receptors expressed by different types of target cell.
The main approach that has been taken to investigate the functions of chemokines and their receptors has been to use targeted recombination to generate 'knockout' mice with specifically inactivated genes, but until recently the insights provided by such studies have been limited. Mice homozygous for a mutation of the MGSA receptor CXCR2, for example, show only subtle abnormalities [5] . Neither mice (Don Cook, personal communication) nor humans [6, 7] lacking functional CCR5 -a ␤-chemokine receptor specific for RANTES, MIP-1␣ and MIP-1␤ -show any obvious deleterious phenotype, though the latter are resistant to infection by macrophage-tropic strains of HIV-1 (recently reviewed in [8] ; see also below). Homozygous MIP-1␣ mutants do not show any obvious defects in their normal physiology, but they do give abnormal responses to viral infections [9] .
The chemokine/chemokine-receptor knockout mice that have been described did not show any obvious developmental abnormality. It is, however, now clear that chemokines have functions that extend beyond their roles in leukocyte migration. Chemokines have been shown to have growth regulatory properties. MGSA, for example, is an autocrine growth factor for melanoma cells and can transform immortalized melanocytes [10] ; and the expression of CXCR2 by maturing keratinocytes suggests that MGSA is also a growth and maturation factor for epidermal cells [11] .
MIP-1␣ has been suggested to be a negative regulator of hematopoietic stem cells, but only recently has a chemokine been shown to play a critical role in hematopoiesis. Nagasawa et al. [12] made mice with a targeted mutation of the gene for a novel C-X-C chemokine, known as stromal derived factor (SDF-1), and the resulting phenotype revealed a role for SDF-1 in embryonic and adult hematopoiesis. SDF-1 supports the growth of a stromal cell-dependent pre-B-cell clone in vitro and its gene maps to chromosome 10, away from the clusters of genes for C-X-C and C-C chemokines on chromosomes 4 and 17, respectively [13, 14] . Interestingly, human and mouse SDF-1 differ at only one amino-acid residue [15] ; this unusually strong sequence conservation itself suggests that SDF-1 has an important physiological function. In line with this notion, the SDF-1 null mutants died in utero [12] , most likely as a result of defective hematopoiesis. The numbers of B-cell progenitors were found to be severely decreased in fetal liver and bone marrow, and although myeloid progenitors populated the fetal liver in normal numbers, they were markedly decreased in the bone marrow.
In humans, adult and fetal hematopoiesis occur at distinct sites: the primary site of hematopoiesis during early embryogenesis is the yolk sac, but by mid-gestation it has moved to the liver and spleen; the bone marrow is not a major contributor to blood-cell formation until very late in fetal development. The fetal hematopoietic stem cells that populate the liver and the analogous adult cells that populate the bone marrow have different properties, either intrinsic to the cells themselves or due to differences in their microenvironments. For example, whereas the proliferation of adult hematopoietic stem cells requires both erythropoietin and a second colony-stimulating factor, such as IL-3 or stem cell factor (SCF), hematopoietic stem cells in embryonic bone marrow can be induced to proliferate by erythropoietin alone [16] . The knockout mice results [12] suggest that one explanation for some of these differences may be the formation of a microenvironment that nurtures the development of hematopoiesis in the bone marrow. One aspect of this microenvironment that may be critical is the secretion of SDF-1 by bone marrow stromal cells.
SDF-1 thus appears to have an important role in establishing hematopoiesis in the bone marrow during development, so identifying its cellular receptor is of prime importance. Two groups [17, 18] have recently reported that the orphan 'leukocyte-expressed seven-transmembrane-domain receptor' (LESTR) confers on cells responsiveness to SDF-1 in Ca 2+ -flux assays; the receptor has thus been renamed CXCR4. Furthermore, in a separate study by one of these groups [19] , SDF-1 was shown to stimulate T-cell migration and actin polymerization in a dose-responsive manner. CXCR4 is highly expressed in leukocytes, has a marked sequence similarity to the IL-8 receptor and its gene has a similar chromosomal localization to the genes encoding other C-X-C chemokine receptors. Interestingly, this receptor was also recently identified [20] as an important entry cofactor for T-cell-tropic, but not macrophage-tropic, HIV-1 strains. The CXCR4 ligand, SDF-1, has accordingly been shown to block cell invasion by T-cell tropic strains of HIV-1 [17, 18] , but not by the macrophage-tropic HIV-1 strains that use CCR5 and perhaps other ␤-chemokine receptors as cofactors for invasion [21, 22] . Despite these recent findings, the importance of chemokines and their receptors in leukocyte production and inflammation remains clear, and this aspect promises to yield valuable insights into the host's repertoire of inflammatory and reparative mechanisms, how they can be subverted by resourceful infectious agents and the strategies the host may invoke to evade this piracy.
